An Exploration of Health Effects of Folic Acid in Pregnancy Beyond Reducing Neural Tube Defects

Journal of Obstetrics and Gynaecology Canada

Volumn 27, Issue 1, 2005, Pages 13-19

  Wen, Shi Wu ^a,b   Walker, Mark ^a,b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

Birth defects; Fetal growth and development; Folate; Folic acid; Homocysteine; Methylenetetrahydrofolate raductase; Multiple births; Placentae; Pregnancy

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); FOLIC ACID; HOMOCYSTEINE;

ARTICLE; FOLATE METABOLISM; FOLIC ACID DEFICIENCY; FORTIFIED FOOD; HUMAN; HYPERHOMOCYSTEINEMIA; INBORN ERROR OF METABOLISM; INFERTILITY THERAPY; MULTIPLE PREGNANCY; NEURAL TUBE DEFECT; PREGNANCY; PREGNANCY OUTCOME; RISK BENEFIT ANALYSIS; RISK FACTOR; SUPPLEMENTATION; SYSTEMATIC REVIEW; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIET SUPPLEMENTATION; FEMALE; HEALTH PROMOTION; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; REVIEW;

DIETARY SUPPLEMENTS; FEMALE; FOLIC ACID; FOOD, FORTIFIED; HEALTH PROMOTION; HUMANS; NEURAL TUBE DEFECTS; PREGNANCY; PREGNANCY OUTCOME; RANDOMIZED CONTROLLED TRIALS;

EID: 21744458599     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1701-2163(16)30166-9     Document Type: Article

References (65)

1. Berry JR, Li Z, Erickson JD, Moore CA, Wang H, Mulinare J. Prevention of neural-tube defects with folic acid in China. N Engl J Med 1999, 341:1485-1490.
2. Czeizel AE, Dudas I. Prevention of first occurrence of neural tube defects by periconceptional vitamin supplementation. N Engl J Med 1992, 327:1832-1835.
3. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 1991, 338:131-137. MRC Vitamin Study Research Group.
4. Lumley J, Watson L, Watson M, Bower C. Periconceptional supplementation with folate and/or multivitamins for preventing neural tube defects. (Cochrane Review). In: The Cochrane library, Issue 3 2001. Oxford: Update Software.
5. Food and Nutrition Board. Standing Committee on the Scientific Evaluation of Dietary Reference Intakes. Approved draft report on folate, other B vitamins and choline 1998, National Academy of Sciences, Institute of Medicine, Institute of Medicine, National Academy of Sciences, Washington (DC), Accessed March 15, 2003. http://books.nap.edu/books/0309065542/html/284.html#pagetop.
6. Nutrition for a healthy pregnancy: guidelines for the child-bearing years 1999, Health Canada, Minister of Public Works and Government Services Canada, Ottawa (ON).
7. Food Standards Agency, U.K. Position in other countries, Annex 6 (folic acid and prevention of disease). Paper FSA; May 2002. Available at: http://www.statcan.ca/english/Pgdb/People/Population/demo01.htm. Accessed March 15, 2003.
8. The Committee on Medical Aspects of Food and Nutrition Policy (COMA), UK. Conclusion by the UK health departments and the food standards agency on the report of the Committee on Medical Aspects of Food and Nutrition Policy on folic acid and the prevention of disease: [conclusions: extracted from the COMA report], July 2002. Available at: http://archive.food.gov.uk/pdf_files/folic_consult.pdf. Accessed March 15,2003.
9. American Academy of Pediatrics. Folic acid for the prevention of neural tube defects [policy statement]. August 1999:325-7.
10. Commonwealth Department of Health and Family Service, Pharmaceutical Society of Australia. A pharmacist's and assistant's guide to folate: helping to prevent neural tube defects. 1997. Available at: http://www.health.gov.au/pubhlth/publicat/document/folate.pdf. Accessed March 15, 2003.
11. The use of folic acid for the prevention of neutral tube defects. [SOGC Policy Statement, No.138] 2003, The Society of Obstetrician and Gynaecologists of Canada, SOGC, Ottawa.
12. Botto LD, Khoury MJ, Mulinare J, Erickson JD. Periconceptional multivitamin use and occurrence of conotruncal heart defects: results from a population-based, case-control study. Pediatrics 1996, 98:911-917.
13. Czeizel AE. Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. Am J Med Genet 1996, 62:179-183.
14. Shaw GM, O'Malley CD, Wasserman CR, Tolarova MM, Lammer EJ. Maternal periconceptional use of multivitamins and reduced risk for conotruncal heart defects and limb deficiencies among offspring. Am J Med Genet 1995, 59:536-545.
15. Shaw GM, Lammer EJ, Wasserman CR, O'Malley CD, Tolarova MM. Risk of orofacial defects in children born to women using multivitamins containing folic acid periconceptionally. Lancet 1995, 346:393-396.
16. Tolarova M, Harris J. Reduced recurrence of orofacial defects after periconceptional supplementation with high-dose folic acid and mutivitamins. Teratology 1995, 51:71-78.
17. Li D-K, Daling JR, Mueller BA, Hickok DE, Fantel AG, Weiss NS. Periconceptional multivitamin use in relation to the risk of congenital urinary tract anomalies. Epidemiology 1995, 6:212-218.
18. Flynn C, Enright H. Fortification of foods with folic acid [letter]. N Engl J Med 2000, 343:971-972.
19. Mills JL. Fortification of foods with folic acid: how much is enough?. N Engl J Med 2000, 342:1442-1445.
20. Ericson A, Kallen B, Aberg A. Use of multivitamins and folic acid in early pregnancy and multiple births in Sweden. Twin Res 2001, 4:63-66.
21. Berry RJ, Kihlberg R, Owen D. Impact of assisted reproductive technologies (ARl) on srudies of folic acid and twinning. Pediatr Perinatal Epidemiol 2004.
22. Li Z, Gindler J, Wang H, Berry RJ, Li S, Correa A, et al. Folic acid supplements during early pregnancy and likelihood of multiple births: a population-based cohort study. Lancet 2003, 361:380-384.
23. Picciano MF. Folic Acid Metabolism in Health and Disease (Contemporary Issues in Clinical Nutrition) 1990, John Wiley&Sons Inc, Hoboken.
24. Duthie SJ, Hawdon A. DNA instability (strand breakage, uracil misincor-poration, and defective repair) is increased by folic acid depletion in human lymphocytes in vitro. FASEB J 1998, 12:1491-1497.
25. Steegers-Theunissen RPM, Smith SC, Steegers EAP, Guilbert LJ, Baker PN. Folate affects apoptosis in human trophoblastic cells. Br J Obstet Gynaecol 2000, 107:1513-1515.
26. Goyette P, Sumner JS, Milos R, Duncan AM, Rosenblatt DS, Matthews RG, et al. Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification. Nat Genet 1994, 7:195-200.
27. Nelen WL, Steegers EAP, Eskes TKAB, Bloom HJ. Genetic risk factor for unexplained recurrent early pregnancy loss. Lancet 1997, 350:861.
28. Sohda S, Arinami T, Hamada H, Yamada N, Hamaguchi H, Kubo T. Methylenetetrahydrofolate reductase polymorphism and pre-eclampsia. J Med Genet 1997, 34:525-526.
29. van der Molen EF, Arends GE, Nelen WL, van der Put NJ, Heil SG, Eskes TK, et al. The mutation 677C-T of the methylenetetrahydrofolate reductase (MTHFR) gene as a new riskfactor for placenta vasculopathy. Am J Obstet Gynecol 2000, 182:1258-1263.
30. Graham IM, Daly LE, Refsum HM, Robinson K, Brattstrom LE, Ueland PM, et al. Plasma homocysteine as a risk factor for vascular disease. J Am Med Assoc 1997, 277:1775-1781.
31. Refsum H, Ueland PM, Nygard O, Vollset SE. Homocysteine and cardiovascular disease. Annu Rev Med 1998, 49:31-62.
32. Rimm EB, Willett WC, Hu FB, Sampson L, Colditz GA, Manson JE, et al. Folate and vitamin B6 from diet and supplements in relation to risk of coronary artery disease among women. J Am Med Assoc 1998, 279:359-364.
33. Schwartz SM, Siscovick DS, Malinow MR, Rosendaal FR, Beverly RK, Hess DL, et al. Myocardial infarction in young women in relation to plasma total homocysteine, folate, a common variant in the methylenetetrahydrofolate reductase gene. Circulation 1997, 96:412-417.
34. Kupferminc MJ, Eldor A, Steiman N, Many A, Bar-AM A, Jaffa A, et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 1999, 340:9-13.
35. Powers RW, Evans RW, Majors AK, Ojimba JI, Ness RB, Crombleholme WR, et al. Plasma homocysteine concentration is increasing preeclampsia and is associated with evidence of endothelial activation. Am J Obstet Gynecol 1998, 179:1605-1611.
36. Rajkovic A, Catalano PM, Manilow MR. Elevated homocysteine levels with preeclampsia. Obstet Gynecol 1997, 90:168-171.
37. De Vries JI, Dekker GA, Huijigens PC, Jakobs C, Blomberg BM, van Geijn HP. Hyperhomocysteinaemia arid protein S deficiency in complicated pregnancies. Br J Obstet Gynaecol 1997, 104:1248-1254.
38. Owen EP, Human L, Carolissen AA, Harley EH, Odendaal HJ. Hyperhomocysteinemia: a risk factor for abruptio placentae. J Inherit Metab Dis 1997, 20:359-362.
39. Vollset SE, Refsum H, Irgens LM, Emblem BM, Tverdal A, Gjessing HK, et al. Plasma total homocysteine, pregnancy complications and adverse pregnancy outcomes: the Hordaland Homocysteine Study. Am J Clin Nutr 2000, 71:962-968.
40. Ray JG, Laskin C. Folic acid and homocycteine metabolic defects and the risk of placental abruption, pre-eclampsia and spontaneous pregnancy loss: a systematic review. Placenta 1999, 20:519-529.
41. Ashworth JR, Warren AY, Johnson IR, Baker PN. Plasma from pre-eclamptic women and functional change in myometrial resistance arteries. Br J Obstet Gynaecol 1998, 105:459-461.
42. Chambers JC, McGregor A, Jean-Marie J, Kooner JS. Acute hyperhomocysteinaemia and endothelial dysfunction. Lancet 1998, 351:36-37.
43. De Wolf F, Brosens I, Renaer M. Fetal growth retardation and the maternal arterial supply in the human placenta in the absence of sustained hypertension. Br J Obstet Gynaecol 1980, 87:678-685.
44. Roberts JM, Taylor RM, Goldfein A. Clinical and biochemical evidence of endothelial cell dysfunction in the pregnancy syndrome preeclampsia. Am J Hypertens 1991, 4:700-708.
45. Nelen WLD, Bulten J, Blom HJ, Steegers EAP, Hanselaar AGJ, Eskes TKA. Association between chorionic villous vascularization and homocysteine concentration in women with unexplained recurrent pregnancy loss? Netherlands J Med 1998;S52-S57.
46. Beall AC, Rosenquist TH. Smooth muscle cells of neural crest origin form the aorticopulmonary septum in the avian embryo. Anat Rec 1990, 226:360-366.
47. Serbedzija GN, Bronner-Fraser M, Fraser SE. Developmental potential of trunk neural crest cells in the mouse. Development 1994, 120:1709-1718.
48. Botto LD, Loffredo C, Scanlon KS, Ferencz C, Khoury MJ, David WP, et al. Vitamin A and cardiac outflow tract defects. Epidemiology 2001, 12:491-496.
49. Mulder GB, Manley N, Grant J, Schmidt K, Zeng W, Eckhoff C, et al. Effects of excess vitamin A on development of cranial neural crest-derived structures: a neonatal and embryologic study. Teratology 2000, 62:214-216.
50. Hernandez-Diaz S, Werler MM, Walker AM, Mitchell AA. Folic acid antagonists during pregnancy and the risk of birth defects. N Engl J Med 2000, 343:1608-1614.
51. Bekkers RLM Eskes TKAB. Periconceptional folic acid intake in Nijmegen, Netherlands. Lancet 1999, 353:292.
52. Kirby RS. Fortification of foods with folic acid [letter]. N Engl J Med 2000, 343:971.
53. Lawrence J, Chiu V, Petitti DB. Fortification of foods with folic acid [letter]. N Engl J Med 2000, 343:970.
54. Oakley GP, Adams MJ, Dickinson CM. More folic acid for everyone, now. J Nutr 1996, 126:751S-755S.
55. Imaizumi Y. A comparative study of zygotic twinning and triplet rates in eight countries, 1972-1999. J Biosoc Sci 2003, 35:287-302.
56. Hasbargen U, Lohse P, Thaler CJ The number of dichorionic twin pregnancies is reduced by the common MTHER 677-T mutation. Hum Reprod 2000, 45:2659-2662.
57. Montgomery GW, Zhao ZZ, Morley KI, Marsh AJ, Boomsma DI, Martin NG, et al. Dizygotic twinning is not associated with methylene-tetrahydrofolate reductase haplotypes. Hum Reprod 2003, 18(11):2460-2464.
58. Ray JG, Merier C, Vermeulen MJ, Boss S, Wyatt PR, Cole DE. Association of neural tube defects and folic acid food fortification in Canada. Lancet 2002, 360:2047-2048.
59. Rosano A, Smithells D, Cacciani L, Botting B, Castilla E, Cornel M, et al. Time trends in neural tube defects prevalence in relation to preventive strategies: an international study. J Epidemiol Community Health 1999, 53:630-635.
60. Honein MA, Paulozzi LJ, Cragan JD, Correa A. Evaluation of selected characteristics of pregnancy drug registries. Teratology 1999, 60:356-364.
61. OECD. Labour force statistics, 1988-1998. Paris: The Organization; 1999. Available at: http://www.statcan.ca/english/Pgdb/People/Population/ demo01.htm. Accessed March 6, 2001.
62. Pastuszak A, Koren G, Milich V, et al. Prospective assessment of pregnancy outcome following first-trimester exposure to benzodiazepines. Maternal and fetal toxicology 1994, 77-88. Marcel Dekker, New York (NY). G. Koren (Ed.).
63. Snow CF. Laboratory diagnosis of vitamin B12 and folate deficiency. Arch Intern Med 1999, 159:1289-2062.
64. Castilla EE, da Gravca Dutra M. Folate awareness among South American women. Lancet 1997, 349:735.
65. Antony AC, Hansen DK. Hypothesis: folate-responsive neural tube defects and neurocristopathies. Teratology 2000, 62:42-50.